Market Data 
Markets
Replies to post #61232 on Blue Diamond Ventures Inc (BLDV)
http://www.marketwired.com/press-release/blue-diamond-ventures-inc-launches-international-cannabis-project-with-ams-canada-pinksheets-bldv-2210922.htm
Alternative Medical Solutions (AMS) is in the final stage to gain a full license to grow, market and sell medicinal cannabis products via Health Canada. BLDV has been working with AMS over the last year to finalize funding for its Fifty (50) thousand square foot cultivation facility. "There has been recognition, by the Canadian Government, for the need to allow import and export in this industry," says Joshua B. Alper, CEO of BLDV. "This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market."
"We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS. "With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation."
http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/application_steps-etapes_lp-pa-eng.php
1. Applications received
2. Preliminary screening
3. Enhanced screening
4. Initiation of security clearance process
5. Review
6. Pre-licence inspection
7. Licensing
http://www.marketwired.com/press-release/blue-diamond-ventures-inc-launches-international-cannabis-project-with-ams-canada-pinksheets-bldv-2210922.htm
Alternative Medical Solutions (AMS) is in the final stage to gain a full license to grow, market and sell medicinal cannabis products via Health Canada. BLDV has been working with AMS over the last year to finalize funding for its Fifty (50) thousand square foot cultivation facility. "There has been recognition, by the Canadian Government, for the need to allow import and export in this industry," says Joshua B. Alper, CEO of BLDV. "This new effort will ensure that AMS, when licensed, will be a Global Project, with their products being available worldwide and with access to the ingredients and technology that will continue to make AMS a leader in the Canadian market."
"We are excited to launch this effort with BLDV," said Joseph Groleau, VP Business Development for AMS. "With the specialized products and technologies coming into Canada from Israel, and access to global markets with our finished products, we see this as a separate profit center that could even outgrow our efforts in cultivation."
CTV London News TV Stories - Key Points
http://london.ctvnews.ca/video?clipId=357998
http://london.ctvnews.ca/video?clipId=357999
** AMS is being built in Hanover Industrial Park in Hanover, Ontario, Canada.
** Mayor of Hanover (Kathi Maskell) supports the project because it will bring up to 60 jobs over a 2 year period and new tax dollars.
https://ca.linkedin.com/in/kathi-maskell-95047547
** City of Hanover gave them the property for Economic development.
** More construction to take place in June 2017.
** AMS expects to have Health Canada approval of permit to move forward with further construction in June 2017.
** Expects to be fully operational and licensed by September 2017.
** City of Hanover Mayor confirms that the city is considered a partner of AMS.
https://www.facebook.com/permalink.php?story_fbid=338152243198125&id=108751362804882
Blue Diamond Consulting, LLC (BDC) a wholly owned subsidiary of Blue Diamond Ventures, Inc. has entered into a Strategic Alliance Agreement to provide services to Alternative Medical Solutions (AMS) a pre-licensed Candian Cultivator located in Ontario, Canada.
AMS is in the process of completing a Fifty Thousand Square foot cultivation facility in Ontario. BDC under the terms of the agreement has already begun providing services as it assists AMS in Securing financing from a private lender in the amount of $12 million USD to finalize construction and build out of its building.
DENVER, CO--(Marketwired - May 26, 2017) - Blue Diamond Ventures Inc. (OTC PINK: BLDV) today announces a strategic partnership with Eltron Research & Development of Boulder Colorado, the creators of the ImPAAct™ Peracetic Acid Generator. Eltron R&D specializes in Material Sciences and adds considerable strength to BLDV on multiple levels.
Cannabis-Clean, a wholly owned subsidiary of BLDV, will work closely with Eltron R&D to roll out the PAA. "This is an exciting new offering; Peracetic Acid is widely used in Cannabis and other industries," said Josh Alper, CEO of BLDV. "The generator is a Patented Device, the only one of its kind, that makes the PAA product on site, on demand."
Steve McMorrow, President of Cannabis-Clean, said, "We are getting up to speed quickly; this agreement gives us the exclusive for the Cannabis Industry in Colorado with a commitment to define expansion to include a partnership for the entire USA." On June 1st, 2017 Cannabis-Clean will be relocating its operations to the Eltron R&D facility in Boulder. "The ImPAAct™ product has really defined our expansion strategy," continued McMorrow. "We have been working with Eltron for 6 months to put this together, and it gives us a sustainable competitive advantage." The new Peracetic Acid Generator has already been approved by the Colorado Department of Agriculture for use in Cannabis Facilities.
BLDV has been named the Representative of Eltron for Israel and Canada and will be facilitating the licensing of the PAA technology in those countries. Blue Diamond Ventures will also use the expertise of Eltron to help achieve the goal of bringing Targeted Cannabis Therapies from Israel to the USA and to Canada as part of the previously announced venture with AMS of Hanover, Canada.
"Eltron R&D provides the laboratory space, the chemists and the material scientists that complete the needs of our partners in Israel," says Josh Alper. "I will be back in Israel next week to finalize our first technology sharing agreements." BLDV will be moving their corporate headquarters into the Eltron space in Boulder in July 2017, joining Cannabis-Clean as part of the agreement.
About BLDV:
Blue Diamond Ventures, Inc. seeks to partner with individuals and companies that share a common synergy, mission and vision to enable products/services that are produced, delivered and consumed utilizing fewer natural resources, providing a sustainable alternative to traditional products on the market today. As a diversified customer, Centric Management / Holding Company, Blue Diamond Ventures, Inc. seeks opportunities in various markets and is driven by critical thinking and the scientific method.
About Eltron:
Eltron Research & Development was founded in 1982 and is a leading R&D organization with over 3 decades of experience providing technology solutions to industry. Our excellent track record of creating commercial-ready technologies has produced 3 spin-off companies and 77 patents, of which 29 have been licensed to industry. Eltron's staff consists of scientists and engineers (Ph.D., MS and BS level) who work in our state-of-the-art research facility in Boulder, Colorado. Eltron's core strengths are applied chemistry and engineering in the following technology areas:
• Energy and Fuels: Clean and sustainable energy, novel biofuels synthesis, fuel reforming, gasification and sequestration
• Catalysts: Design, synthesis, evaluation and scale-up of heterogeneous and homogeneous, supported and unsupported materials
• Advanced Materials: Polymers, membranes, multifunctional composites, ceramics, novel paints and coatings, chemical energy storage systems, materials molding and nanotubes
• Chemicals & Chemical Processing: Ambient and high temperature chemical processes as well as electrochemical methodologies
• Environmental: Green electrolytic water treatment technology, contaminant remediation, and sensor technology platforms
Eltron's clients come from both private and public sectors. Eltron has completed more than 200 projects over 3 decades for many government agencies including the DOE, DOD, NASA, EPA, NIH and NSF.
http://www.eltronresearch.com/
The IMPAACT ?on-site peracetic acid generator provides PAA mixtures with flexible pH ranges (from 2- 13) and for point of use applications (from single digit ppm to 30,000 ppm PAA concentrations).
Although dosage requirements for industrial grade bleach (Sodium Hypochlorite) and PAA are applied at a similar rate, PAA does not require a dechlorination step because PAA is an effective broad spectrum biocide that avoids formation of halogenated disinfection byproducts. Eltron Water Systems has 1 patent
and 2 patents pending.
“We have spent over a decade on the research and development of this water technology and now that we have secured these two requirements with the FDA and EPA, we are aggressively entering the market,” said Eltron Water Systems President Paul Grimmer, “We look forward to providing a cheaper and more green product to both PAA end-users and suppliers for their anti-microbial needs.”
AI
